Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

FDA Clearance to Remanufacture Da Vinci Robotic Instruments Could Present Hospitals with Substantial Savings


EndoWrist is a significant cost driver at U.S. hospitals, and we can now provide them with the option of reducing these costs significantly without having to abandon good instrumentation and the ability to perform robotic surgeries.

Iconocare, a healthcare cost containment company, today announced it has received FDA 510(k) clearance (#K210478) to remanufacture and market used EndoWrist SI robotic attachments (8mm Monopolar Curved Scissors) originally produced by Intuitive Surgical, Inc., the company behind the Da Vinci robotic system.

Da Vinci robots are widely used in U.S. hospitals, and reusable accessories used in robotic procedures are very expensive and limited by the manufacturer to typically 10-15 uses. However, they can be used many more times when going through a controlled remanufacturing process without losing functionality. Encore Medical Device Repair has exclusive distribution rights to FDA cleared remanufactured EndoWrist SI, and access to the EndoWrist XI is expected soon.

Remanufactured EndoWrist is significantly less expensive than new EndoWrist and can save the hospital hundreds of thousands of dollars. Using remanufactured EndoWrist poses no additional patient risk, and devices function as new.

“EndoWrist is a significant cost driver at U.S. hospitals, and we can now provide them with the option of reducing these costs significantly without having to abandon good instrumentation and the ability to perform robotic surgeries. This is the only FDA clearance for a robotic instrument, and we are very excited for the financial relief we can now provide to hospitals,” says Tom Milano, President & COO of Encore Medical Device Repair.

Iconocare is a healthcare cost containment company offering provider-focused healthcare solutions combining financial responsibility and healthcare technology to improve patient care.

Encore Medical Device Repair was founded in 2022 on the vision that device and instrument reuse should play a key role in responsible healthcare. To achieve this, the founders knew they had to raise the level of quality, sophistication, transparency, and service in the industry. A focus on the highest-price, highest-utilization instrument categories allows encore to employ the most qualified technicians and deliver unparalleled service while containing costs.

Share article on social media or email:

Corza Ophthalmology Partners with Vortex Surgical to Enter the Vitreoretinal Surgical Space


News Image

“Vortex Surgical and Corza Ophthalmology share a vision of partnering closely with surgeons to discover, develop and deliver high-quality surgical solutions that drive exceptional clinical value.” – Gregory T. Lucier, Executive Chairman of Corza Medical

Corza Ophthalmology has formed a commercial partnership with Vortex Surgical to serve the vitreoretinal surgical community. Corza Ophthalmology’s well-established portfolio of high-quality brands like Katena instruments, Sharpoint microsurgical knives, Blink single use instruments and several others strongly compliments Vortex’s industry leading, innovative line of vitreoretinal instrumentation.

“Vortex Surgical and Corza Ophthalmology share a vision of partnering closely with surgeons to discover, develop and deliver high-quality surgical solutions that drive exceptional clinical value.” said Gregory T. Lucier, Executive Chairman of Corza Medical. “Through this partnership with Vortex, we will extend our goals of providing remarkable service, trusted performance and outstanding value to the vitreoretinal space.”

“The combination of Vortex’s strong innovation engine with Corza Ophthalmology’s commercial infrastructure will drive exceptional value for surgeons, clinics and patients.” said Jack Simmons, VP & GM of Corza Ophthalmology. “We look forward to that partnership with the Vortex team.”

Mike Fanning, Vortex CEO added “Corza Ophthalmology has quickly shown its commitment to the global ophthalmic surgical market. This partnership brings together two organizations aligned on delivering innovation and institutional efficiency through service, high-quality, and purposeful customer engagements.”

Vortex’s portfolio is now fully available through Corza Medical and supported by the Corza Ophthalmology selling, marketing and medical education team. For ordering information, please visit http://www.corzaeye.com, reach out to your local Corza Ophthalmology sales representative, or contact customer service (+1 973-989-1600 or inquiries@corza.com).

About Corza Medical

Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 2000 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single use ophthalmic instruments, Sharpoint® ophthalmic, and the TachoSil® fibrin sealant patch. For more information, please visit http://www.corza.com

About Vortex Surgical

Formed in 2016 and with headquarters in St. Charles, MO, the Vortex Surgical team has over 175 years of combined expertise in the design, development, manufacturing, and commercialization of innovative consumables and capital equipment for vitreoretinal surgery. Through a customer centric model, focused on continuous improvement, Vortex is dedicated to exceeding customer expectations with high quality, clinically significant products and services that enhance ocular surgery and patient outcome. For more information, please visit http://www.vortexsurgical.com

Share article on social media or email:

ThriveAP Enters Acute Care with New Hospitalist Transition to Practice Curriculum


“At ThriveAP we are proud to continually provide unmatched curriculums, regardless of care setting, with the proven ability to increase RVUs, retention and overall satisfaction for advanced practice providers across the nation,” said Jim Creason, President & CEO for ThriveAP.

ThriveAP, the leading transition to practice educational solution for advanced practice providers (APPs), is excited to announce our newest transition to practice curriculum, Acute Care focused Hospitalist Medicine.

“At ThriveAP, we know Nurse Practitioners and Physician Assistants /Associates play a critical role during the delivery of inpatient care. We aim to support advanced practice providers through a meaningful approach that will advance strategic growth in an acute care setting, while driving provider confidence and meeting market-demand,” said Veronica Hill, DNP, CRNP, Vice President of Programs and Content at ThriveAP.

The Hospitalist Medicine program helps providers practice at the top of their licensure through a 12-month, live and virtual curriculum taught by actively practicing, board-certified experts. The evidence-based curriculum focuses on clinical competency and professional development that translates provider knowledge into confident application. The Acute Care focused program consists of 10 core curriculum blocks:

  • Foundations of Hospital Medicine
  • General Medicine
  • Neurology
  • Cardiovascular
  • Nephrology
  • Endocrine
  • Gastroenterology
  • Infectious Disease
  • Pulmonary Medicine
  • Palliative Medicine

To develop the Acute Care program, ThriveAP engaged a committee of healthcare systems. The committee collaborated in the development of the program to compare goals, visions, and challenges. ThriveAP incorporated common diagnoses, best practices, and proven techniques from the Department for Health and Human Services, the Society of Hospital Medicine, our collaborative committee, and our existing program to achieve our unique Acute Care transition to practice solution.

“Being part of the collaborative development committee for the Hospitalist Medicine program was important to us because at the University of Tennessee Medical Center we recognize that providing continuing educational opportunities and supporting the development of our APPs results in measurable value for the provider, their healthcare team, and patients. This is why we place great emphasis on supporting new graduates as they transition into practice,” said Chris Ferron, MBA, PA-C, Director of Advanced Practice, University of Tennessee Medical Center. “We believe the curriculum blocks paired with clinical discussions and professional development topics successfully meet the needs and quality expectations of inpatient care.”

“It is important to us, at ThriveAP, to provide enhanced educational opportunities across the spectrum of care, enabling providers to practice at the top of licensure, regardless of care setting,” said Jim Creason, President and CEO of ThriveAP. “We are proud to continually create unmatched curriculums with the proven ability to increase RVUs, retention and overall satisfaction for advanced practice providers across the nation. We look forward to launching even more curriculums in 2023.”

The Hospitalist Medicine transition to practice curriculum boasts rolling enrollment and is available now! For more information on the program visit: https://www.thriveap.com/acute-care/hospitalist-medicine

About ThriveAP

Founded in 2012, ThriveAP has become an important education resource for Advanced Practice Providers and their employers throughout the nation. ThriveAP’s programs help facilitate the growing impact of APPs in the delivery of healthcare and is recognized for its quality, relevance, and convenience. The ThriveAP program blends interactive educational experiences, community, and support to improve provider productivity, proficiency, and confidence through real-world skill development. Learn more, ThriveAP.com

Share article on social media or email:

Health Connect America Celebrates New Services and Brings New Jobs to Johnson City


Health Connect America (HCA), a provider of mental and behavioral health services, plans to hire additional staff in recognition of its growth and increased service offerings in the Johnson City area. The local office provides Intensive In-Home services for children and families in need of stabilization, Intensive Outpatient therapy for co-occurring substance abuse and mental health diagnosis and is a Tennessee Health Link provider. HCA is planning an ABA Clinic Services for children with Autism.

On November 14, 2022, at 10 am EST HCA’s Johnson City office is partnering with the Chamber of Commerce and celebrating its growth and variety of new services with a ribbon cutting.

“Northeastern Tennessee is an important market area for HCA,” says Kristi Shain, president and chief executive officer, Health Connect America. “Services designed for the needs of each community we serve are the key to our commitment to offer this underserved population a higher level of care. This will be a great opportunity for those seeking employment and/or our wide range of services to celebrate this new chapter with the Johnson City Community!”

The existing range of programs help adults, children, adolescents and families find hope and healing from traumatic events and supports with intellectual and developmental disabilities. These programs are designed to address issues like grief, anger management, family issues, substance use, autism diagnoses and intellectual disabilities. Individuals are offered the support they need to help improve the lives of children, adults and their families.

“Our projected growth not only benefits the community by serving more clients, but also creates more jobs in the area,” says Dave Krikac, vice president of operations for Health Connect America. “The variety of programs available will allow treatment to be individually tailored to client needs, legal requirements for individuals, and overall community enhancement.”

The In-Home Services program continues to grow and evolve, requiring ongoing hiring to meet community needs. The availability of these programs will increase access to resources for clients with the highest level of need. This will also decrease wait times between a need being identified and care being provided.

More about Health Connect America services programs are listed here: https://www.healthconnectamerica.com/tennessee-services-and-programs/.

Another important outreach feature of HCA is their foster program. Visit here to learn more:

https://www.healthconnectamerica.com/become-a-foster-parent/?fbclid=IwAR27kEvREcf5DZ3JcfVW0Z7ySkLBg3RBlK5NG7m7zQ_rd5JSFf8rpx60K_M

About Health Connect America

Health Connect America (HCA) provides mental and behavioral health services to children, families, and adults across 56 locations across five states impacting the lives of nearly 10,000 people daily. The organization is honored to be a part of the communities served walking with clients as they embark on a journey to self-improvement and more fulfilling lives. Health Connect America provides services where clients need them – within the community, the home, or in one of the organization’s many locations. Through a vast network of direct care professionals, HCA is readily available to meet the needs of both clients and their families. The services delivered include one-on-one or family counseling, case management, autism services, or medication management for children, adults, and families. These services promote positive personal growth, develop healthy coping skills, preserve and repair relationships and natural support systems. For more information see https://www.healthconnectamerica.com/.

Share article on social media or email:

TwelveStone Health Partners Announces New CFO Clint Hill


Clint Hill, chief financial officer

TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, announced today that Clint Hill will take over as chief financial officer allowing Jozef Nuyens to transition to a new position as TwelveStone’s chief strategy officer.

Clint’s arrival comes on the heels of the successful Funding from Heritage Group this summer which has allowed TwelveStone’s aggressive expansion efforts. Hill is a seasoned financial and operations professional with extensive background in healthcare spanning more than 20+ years of progressive management experience.

“Clint is a proven chief financial officer with deep healthcare experience making him a great addition to the leadership team as we continue on our strong growth trajectory,” says Shane Reeves, chief executive officer, TwelveStone Health Partners.

Most recently Hill was a chief financial officer at both Halo Diagnostics, a software company and multi-specialty practice operator; and Apricity Resources, a shared services company offering a full suite of back-office support services to multiple clients. Prior to Apricity, he held senior finance positions at Diversicare Healthcare Services and Outpatient Imaging Affiliates. His academic background includes an undergraduate degree from Lipscomb University and an MBA from Belmont Graduate School of Business.

“I am excited to work with the team at TwelveStone leveraging my past experience to help TwelveStone continue to grow and offer an exceptional level of care to our patients,” says Clint Hill, chief financial officer, TwelveStone Health Partners.

Find Clint Hill on LinkedIn here.

About TwelveStone Health Partners

TwelveStone Health Partners incorporates the objective of glorifying God into its mission by delivering a higher level of service to partners and patients. As an organization, TwelveStone supports the transition from acute to post-acute care environments and the transition from sickness to health. Founded in 2016 TwelveStone is the third iteration of pharmacy organizations founded by Shane Reeves and the Reeves family. Today TwelveStone is rapidly expanding across the Southeast anchored by spa-like infusion centers conveniently located in suburban communities supported by additional services including package medications, home infusion, enteral and injections. TwelveStone is dedicated to providing the highest level of care to those with chronic, complex conditions in the environment that is most convenient for both the patient and their loved ones. For more information, visit http://www.12stonehealth.com.

Share article on social media or email:

Great Valley Publishing Receives Interprofessional Joint Accreditation to Benefit Healthcare Teams


Great Valley Publishing (GVP) announces that it has been awarded Joint Accreditation for Interprofessional Continuing Education™ (Joint Accreditation) as a provider of interprofessional continuing education (IPCE). Joint Accreditation is awarded by three national institutions at the forefront of IPCE — the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nursing Credentialing Center (ANCC) — and is the gold standard for continuing education for physicians, pharmacists, and nurses, as well as other healthcare professionals including registered dietitians, social workers, physician assistants, psychologists, optometrists, dentists, and athletic trainers.

Recognition as a Jointly Accredited Provider certifies that GVP’s educational activities have been planned by and for the healthcare team. Additionally, the award of Joint Accreditation aligns GVP with some of the most prestigious US medical schools, hospitals, and national medical associations. Joint Accreditation ensures that continuing education for healthcare teams serves the needs of patients and the public, and is designed to be independent, free from commercial bias, based on valid content, relevant, and effective in improving the safety of care delivered by the healthcare team.

According to national continuing education advisor, Steven Passin, President of Steve Passin & Associates, “Great Valley Publishing’s inclusion into the ranks of organizations that are Jointly Accredited places them among those medical educators that have demonstrated the highest levels of educational acumen based on quality and patient safety parameters consistent with identified needs of the healthcare team.”

Mara Honicker, CEO and Publisher of GVP, added, “This acknowledgement of Great Valley Publishing’s performance-in-practice further empowers our core educational mission to provide relevant, timely, and independent continuing education to physicians, registered dietitians, and other members of the care team to improve learners’ abilities to apply new knowledge, and skills/strategy in practice to support improved patient outcomes in the context of team-based care.”

Receipt of Joint Accreditation assures health professionals and the public that continuing education activities provided by GVP meet the high standards of the Criteria for Accreditation and the Standards for Integrity and Independence of Joint Accreditation for Interprofessional Continuing Education, the ACCME, the ACPE and the ANCC. The aforementioned accreditors rigorously evaluate the overall continuing programs of institutions according to standards adopted by all sponsoring organizations and further includes the parent organizations of the ACCME, the American Board of Medical Specialties, the American Hospital Association, the American Medical Association, the Association for Hospital Medical Education, the Association of American Medical Colleges, the Council of Medical Specialty Societies, and the Federation of State Medical Boards.

About Great Valley Publishing

Great Valley Publishing Company has been serving health professionals for over 30 years. Current media channels target specific audiences within several areas of health care — dietetics, radiology, aging care, social work, and health information management. Today’s Dietitian, Radiology Today, Today’s Geriatric Medicine, Social Work Today, and For The Record, are each leaders in their respective fields.

For more information about GVP’s continuing education program, please contact Jack Graham, Director of Continuing Education, at (267) 715-0900.

###

Share article on social media or email:

The National Birth Equity Collaborative Partners With Cortavo for Managed IT and Cybersecurity


NBEC & Cortavo Logo JPEG

The Cortavo team is honored to work with organizations like NBEC, whose mission seeks to improve quality-of-life outcomes for disadvantaged Black communities. – Tiffany Bloomer, President of Cortavo

The National Birth Equity Collaborative (NBEC) has embarked on a partnership with the Atlanta-based managed IT service provider Cortavo for its managed IT solutions. Cortavo was founded to help small to mid-sized businesses by providing complete and affordable IT solutions. Their mission is to remove the complexity of business IT and provide everything businesses need to be successful, from cybersecurity, unlimited service desk support, hybrid workplace solutions, office connectivity, cloud data storage, hardware and software. Cortavo’s all-inclusive IT plans and support are designed to scale with businesses as they grow.

“As the world becomes increasingly virtual, NBEC’s leaders felt the need to engage business technology experts that can assist us in keeping up with this rapidly changing society,” said Shani Hunter, Chief of Staff for the National Birth Equity Collaborative. “Cortavo is an award-winning, industry-recognized company that is ahead of the curve. It is only natural that NBEC utilizes its services to assist us in supporting Black women, Black birthing people and their villages as we focus on advocacy transnationally.”

NBEC is one of the nation’s leading experts in, and an advocate for, change in the Black maternal health and infant mortality crises. As an organization focused on the sexual and reproductive health and wellbeing of Black women and birthing people world-wide, NBEC creates transnational solutions that optimize Black maternal, infant, sexual and reproductive wellbeing.

Established in 2015 by Founder and President Dr. Joia Crear-Perry, NBEC was created to combat the increasing rate of infant mortality within the most marginalized populations. Recognizing that ensuring better care for Black babies had to start with better care for Black mamas, NBEC expanded its mission to focus more on the mother’s experience along with baby’s in hopes of creating safe and healthy conditions for both moms and their babies. Our vision is that all Black mothers, their babies and their villages thrive.

“The Cortavo team is honored to work with organizations like NBEC, whose mission seeks to improve quality-of-life outcomes for disadvantaged Black communities,” said Tiffany Bloomer, President of Cortavo. “NBEC is a growing organization facing an outpour of public interest in their mission, couple­­­­d with their commendable social goals.”

Tiffany acknowledged that growth was a common challenge faced by many of the businesses that rely on Cortavo’s managed IT service.

“Growth is a good problem to have. And as NBEC faces it head-on, Cortavo is here to help them scale efficiently as they rapidly expand to meet the challenges of their mission. Reliable IT infrastructure, managed IT services and unlimited service desk support will position NBEC for great success and keep them on that path for many years to come.”

ABOUT NBEC

The National Birth Equity Collaborative (NBEC) is a fiscally sponsored program of the The Praxis Project, a 501(c)(3) public charity. Founded by Dr. Joia Crear-Perry, NBEC is one of the nation’s leading experts and an advocate for change in the Black maternal health and infant mortality crises. NBEC’s mission is to create transnational solutions that optimize Black maternal, infant, sexual and reproductive wellbeing. We shift systems and culture through training, research, technical assistance, policy, advocacy and community-centered collaboration. To learn more visit http://www.birthequity.org for more information.

Connect with NBEC on social media:

LinkedIn: https://www.linkedin.com/company/birthequity/

Twitter: https://twitter.com/BirthEquity

Facebook: https://www.facebook.com/birthequity/

Instagram: https://www.instagram.com/birthequity/

About Cortavo

Cortavo is the only all-inclusive managed IT solution providing unlimited service desk support, cybersecurity, internet connectivity, cloud data storage, computer hardware and software necessary to manage small to medium-sized business technology needs at a flat monthly fee. Cortavo is based in Atlanta, GA and supports thousands of small business employees throughout the southeastern United States. For more information about Cortavo and its services, visit http://www.Cortavo.com.

Connect with Cortavo on social media:

LinkedIn: https://www.linkedin.com/showcase/cortavo/

Twitter: https://twitter.com/cortavo

Facebook: https://www.facebook.com/CortavoByAventisSystems/

Share article on social media or email:



The Society for Immunotherapy of Cancer to Hold Press Briefing on Nine Abstracts to be Presented at 37th Annual Meeting


News Image

The Society for Immunotherapy of Cancer (SITC) invites you to attend the virtual press briefing of the society’s 37th Annual Meeting (SITC 2022) beginning at 11:30 a.m. EST on Tuesday, Nov. 8, 2022.

The abstracts selected for the press briefing represent an array of the top advances in cancer immunotherapy research. Regular and late-breaking abstracts are embargoed until 8 a.m. EST, Nov. 7, 2022. Data shared during the presentation is embargoed until that date unless otherwise stated during the press briefing. For more information, please review the SITC 2022 Media Policy.

The presentations scheduled to occur during the press briefing are listed in order below:

Abstract #558: CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study

  • Presenter: Sumanta K. Pal, MD – City of Hope Comprehensive Cancer Center

Abstract #755: Results of a phase I trial of FT500, a first-in-class, off-the-shelf, iPSC derived NK cell therapy combined with PD-1/PD-L1 checkpoint blockade therapy and IL-2 in patients with advanced solid tumors

  • Presenter: Sandip P. Patel, MD – University of California, San Diego

Abstract #789: Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144-01 study)

  • Presenter: Amod A. Sarnaik, MD, FACS – H. Lee Moffitt Cancer Center

Abstract #568: Phase 2 trial of induction and concomitant CTLA4 (ipilimumab) and PD-1 (nivolumab) immune checkpoint blockade and intensity modulated radiation therapy (IMRT) in HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC)

  • Presenter: Maura L. Gillison, MD, PhD – The University of Texas MD Anderson Cancer Center

Abstract #605: Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

  • Presenter: Diwakar Davar, MD – University of Pittsburgh Medical Center Hillman Cancer Center

Abstract #614: Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patients

  • Presenter: Saman Maleki, PhD – Western University, London, Canada

Abstract #711: Interim results of a phase 2 study of nivolumab and relatlimab in advanced mismatch repair deficient (dMMR) cancers resistant to prior PD-(L)1 inhibition

  • Presenter: Katherine M. Bever, MD – Johns Hopkins University


Abstract #1470: Combining the antigen-presenting cell activator eftilagimod alpha (soluble LAG-3) and pembrolizumab: efficacy results from the 1st line non-small cell lung cancer cohort of TACTI-002 (Phase II)

  • Presenter: Wade T. Iams, MD – Vanderbilt University Medical Center

Abstract #1478: A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells

  • Presenters: Stefanie Mandl, PhD – PACT Pharma


        Antoni Ribas, MD, PhD – University of California, Los Angeles

ADDITIONAL DETAILS:

Participating members of the media will have the opportunity to submit questions via chat for up to three minutes following each presentation. To attend this press briefing, you must register as a member of the press for SITC 2022. To register, please visit https://www.sitcancer.org/2022/press/press-registration. After registration is confirmed, you will receive instructions for the briefing. For more information regarding SITC 2022, please visit the Annual Meeting website at http://www.sitcancer.org/2022.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, and YouTube.

Share article on social media or email:



Brevi-T, a Joint Venture between InterOme and Avrok Biosciences Will Change the Way We Understand and Solve Society’s Most Urgent Problems


Brevi-T Logo

“We aim to support every individual, community, and global network with precision public health solutions.” – Corina Shtir, Ph.D., CEO at InterOme

Brevi-T, a joint venture between InterOme, a trailblazing digital health enterprise, and molecular laboratory innovator Avrok Biosciences, is tackling some of the world’s most daunting public health challenges, including infectious disease, substance abuse, and environmental contamination.

Brevi-T revolutionizes the detection, assessment, analysis, and management of public health risk factors to prevent the spread of epidemics. The innovative, end-to-end ecosystem, which includes consistent process management and analytics, delivers centralized, actionable data to inform decision-making that greatly improves practices, plans, and policies for the best possible individual and public health outcomes.

Brevit-T is the first-ever single source solution that combines cutting-edge field sampling and laboratory testing with advanced data analytics and accessible user-friendly software in an effortless framework for day-to-day use by individuals, communities, districts, and private and public institutions. The customizable dashboard features a user-friendly interface that virtually anyone can use.

This seamless integration of automated wastewater testing, individual testing (when desired), real-time data enrichment, advanced analytics, reporting, and alerts delivers rapid, accurate results on a number of risk factors including, but not limited to pathogens, drugs of abuse, and environmental contaminants

The system brings an unprecedented level of efficiency, accuracy, automation, and speed to testing, analysis, and reporting, and makes understanding and communicating results and action plans simple and easy. Additionally, enriched real-time demographic, health, and environmental data makes predictive analysis and modeling possible.

This in turn can be used to anticipate where the next disease outbreak may be coming from, monitor the prevalence of illicit drug use to provide better education and support, or stay ahead of potentially harmful environmental conditions that may impact the health of the local community.

“Our goal is to solve general systemic problems through highly specialized approaches,” said Corina Shtir, Ph.D., CEO at InterOme. “Through our partnership with Avrok Biosciences, we escalated our impact exponentially by creating an ecosystem that allows us to shift epidemiology studies from retrospective to real-time monitoring, including prospective measures. We aim to support every individual, community, and global network with precision public health solutions.”

“Partnering with InterOme has been a natural fit from the very beginning,” said Jonathan Martin, COO at Avrok. “Their focus on public health, precision medicine, and passion for empowering patients to be more involved with their health data complements Avrok’s mission to help the population at large to fight against epidemics through awareness and prevention.”

About Brevi-T:

Brevi-T is a joint venture between InterOme and Avrok Biosciences. Brevi-T’s mission is to make the world a healthier place, by creating the means to detect, assess, manage, and prevent public health risk factors and infectious disease global pandemics. Through this global collaboration, the company harnesses the best experience and expertise into a business and industry framework that focuses on harm reduction and keeping people as healthy as possible. Harm reduction improves health outcomes by using actionable data to inform and support the best possible individual and public health outcomes. For additional information, please visit https://brevitbio.com/

About InterOme, Inc:

InterOme Inc. aims to close the gaps that slow down health-related decision-making and develop solutions that accelerate health from the individual to the community. InterOme works collaboratively with the precision medicine and public health communities to improve outcomes and accelerate health outcomes via specialized solutions that are scalable, cost-effective, and time efficient. InterOme brings together a team of expert physicians, scientists, and software developers with experience building enterprise-class solutions for private, public, and hybrid customers. For additional information, please visit https://interome.com/.

About Avrok Biosciences:

Avrok Biosciences is a CAP/CLIA-accredited molecular laboratory. Avrok was founded by experts in genetic testing and research, with a team of industry experts with over 50 years of combined experience who have dedicated their careers to science and medicine; together they have over 50 years of experience in oncology, diagnostics, and drug testing. Avrok has extensive experience with molecular assay development utilizing quantitative real-time PCR, microarray, mass spectrometry, and NGS and is focused on translating research assays into CAP/CLIA compliant laboratory developed tests. For additional information, please visit https://avrokbio.com/.

Share article on social media or email:

Protect Me With 3+ contest submissions now open for NJ middle, high school students to raise vaccine awareness


Participation is a critical component of teaching students to be good citizens and health messengers among peers and family.

Calling all New Jersey middle and high school students! This year’s Protect Me With 3+ vaccine awareness contest is now open for poster and video submissions through Jan. 20, 2023.

To stimulate creativity through health education, this year’s Create. Educate. Vaccinate. contest seeks to motivate students to create posters and videos illustrating the importance of getting vaccinated to achieve the highest level of community protection. The goal is to use the power of students’ creativity to raise awareness of the importance of vaccines in protecting New Jerseyans’ health and encourage more students and teachers to participate statewide.

“This year’s revitalized contest seeks to not only increase and diversify contest submissions but empower adolescents and educators to join in the fun to improve community health through vaccine awareness,” said Mariekarl Vilceus-Talty, MA, BSN, President & CEO of the Partnership for Maternal and Child Health of Northern New Jersey (PMCH). “Participation is a critical component of teaching students to be good citizens and health messengers among peers and family.”

Students in grades 5–12 are encouraged to design an 8.5×11 poster (by hand or digitally) or create a :30 video for an opportunity to win a $50-$300 Visa gift card. Artwork must feature educational information about one of the following vaccines: COVID-19; Tetanus, Diphtheria, Pertussis (Tdap); Human Papillomavirus (HPV); Meningococcal ACWY; and Flu. Full details and examples of past winners’ artwork are available at protectmewith3.com.

Vaccines play a vital role in keeping New Jersey communities healthy. They are the safest and most effective tools to help prevent serious symptoms and complications. The Centers for Disease Control and Prevention recommends vaccinations from birth through adulthood to provide a lifetime of protection against many diseases and infections.

“Vaccine-preventable diseases can affect anyone, regardless of age or health status, including healthy teens. Young and healthy people are not immune to serious illnesses,” said Dr. Christina Tan, New Jersey Department of Health (DOH) Assistant Commissioner and State Epidemiologist. “The best time to get vaccinated is before exposure to dangerous diseases. This contest helps inspire the next generation of artists and educators to contribute their creative talents to educate their communities.”

Digital entries can be submitted here. Hand-drawn posters can be mailed to:

The Partnership for Maternal and Child Health of Northern New Jersey

50 Park Place

Suite 700

Newark, NJ 07102

Middle school prizes

Poster

  • 1st place: $125
  • 2nd place: $75
  • 3rd place: $50

Video

  • 1st: $250
  • 2nd: $150
  • 3rd: $100

High school prizes

Poster

  • 1st place: $125
  • 2nd place: $75
  • 3rd place: $50

Video

  • 1st: $300
  • 2nd: $200
  • 3rd: $100

Three teachers whose classes submit the most submissions will win $75 each. Submissions entered before Jan. 6, 2023 will be eligible for an early bird prize of $50. Three early bird winners will be randomly selected. Finalists will be selected in March 2023, and an award celebration will be held in May to honor winners and participants.

The Protect Me With 3+ contest is a collaboration between PMCH and DOH.

Share article on social media or email: